Literature DB >> 163277

Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.

C Le Prevost, E Levy-Leblond, J L Virelizier, J M Dupuy.   

Abstract

Humoral and cell-mediated immune responses were studied in resistant and susceptible strains of mice infected with mouse hepatitis virus type III (MHV 3). Virus was maintained by regular passages in susceptible DBA/2 mice and assayed in DBA/2 mice by LD-50 determination. Normal resistant A strain mice were able to clear the virus from liver, brain, and serum within 7 days after infection. No neutralizing antibody was found. Transfer of serum from immunized A strain mice was not effective in protecting susceptible DBA/2 mice against challenge with virus. In A strain animals resistance to MHV-3 developed rapidly during the 3rd week of life. During the period of susceptibility, newborns were protected neither by transplacental passages of anti-MHV-3 antibodies nor by injection of "educated" thymus cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163277

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

Authors:  J L Virelizier; A C Allison; E de Maeyer
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Correlation of persistent mouse hepatitis virus (MHV-3) infection with its effect on mouse macrophage cultures.

Authors:  J L Virelizier; A C Allison
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

4.  Specific T-cell response correlates with resistance of genetic heterogeneous mouse populations to mouse hepatitis virus 3 infection.

Authors:  R C Vassão; W H Cabrera; O C Ibanez; C A Pereira
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.

Authors:  L M Lamontagne; J M Dupuy
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

6.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Ependymitis, leukoencephalitis, hydrocephalus, and thrombotic vasculitis following chronic infection by mouse hepatitis virus 3 (MHV 3).

Authors:  M Tardieu; A Goffinet; G Harmant-van Rijckevorsel; G Lyon
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

8.  Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Brief report.

Authors:  M R Macnaughton; S Patterson
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.

Authors:  I G Mello; R C Vassão; C A Pereira
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Macrophage interleukin-6 and tumour necrosis factor-alpha are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a.

Authors:  Alexandre Jacques; Christian Bleau; Claire Turbide; Nicole Beauchemin; Lucie Lamontagne
Journal:  Immunology       Date:  2009-08-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.